International Expansion of Japanese Healthcare
First written in FY2016-Q2. 16 of 28 entries say "Advanced", first in FY2016. Latest entry: 2026-08-13.
No other company in this theme has enough history to compare yet.
- FY2025-H1AdvancedAnnual report
「Going forward, while strengthening our strength in treatment-related services, we will expand healthcare, healthy aging and anti-aging services at the pre-disease stage for health-conscious people. We will renew our operating structure to capture these changes in the market structure, strengthen cooperation with medical institutions and agents in Japan and overseas, and aim to become a platform for international medical exchange.」
Regarding the international expansion of Japanese medical services, the company indicates that it will strengthen treatment services as well as the healthy aging, pre-disease and anti-aging fields, while advancing cooperation with medical institutions and agents in Japan and overseas. - FY2024AdvancedAnnual report
「Revenue increased from the previous fiscal year as the number of projects rose. In China, interest in healthcare and healthy aging at the pre-disease stage is growing, and demand from Vietnam, South Korea and other countries is also trending upward. We will renew our operating structure to capture these changes in the market structure, strengthen cooperation with medical institutions and agents in Japan and overseas, and aim to become a platform for international medical exchange.」
The international medical business is progressing through increases in the number of projects and revenue, renewal of its operating structure based on demand from China, Vietnam, South Korea and other markets, and stronger cooperation with medical institutions and agents in Japan and overseas. - FY2024-H1RestatedAnnual report
「The international medical business (medical tourism) is gradually recovering, and revenue has increased year on year. In China, interest in healthcare and healthy aging at the pre-disease stage is growing, and demand from Vietnam, South Korea and other countries is also trending upward. We will renew our operating structure to capture these changes in the market structure, strengthen cooperation with medical institutions and agents in Japan and overseas, and aim to become a platform for international medical exchange.」
The company reaffirms its direction of recovery in the international medical business, healthcare demand in China and other markets, renewal of its operating structure, and stronger cooperation with medical institutions and agents in Japan and overseas. - FY2024-Q1ReframedAnnual report
「The international medical business (medical tourism) is gradually recovering, and revenue has increased year on year. In China, interest in healthcare and healthy aging at the pre-disease stage is growing, and demand from Vietnam, South Korea and other countries is also trending upward. We will renew our operating structure to capture these changes in the market structure, strengthen cooperation with medical institutions and agents in Japan and overseas, and aim to become a platform for international medical exchange.」
In light of the international medical business's recovery trend and rising demand, the company is broadening its stated direction from receiving patients and strengthening medical-institution networks to renewing its operating structure to capture changes in the market structure and aiming to become a platform for international medical exchange. - FY2023AdvancedAnnual report
「The international medical business (medical tourism) has not yet returned to pre-pandemic levels but is gradually recovering, and revenue has increased from the previous fiscal year. In anticipation of further demand growth, we are strengthening our operating structure, including by building networks with domestic medical institutions.」
Although the international medical business has not recovered to pre-pandemic levels, revenue increased from the previous fiscal year, and the company continues to build networks with domestic medical institutions. - FY2023-Q3AdvancedAnnual report
「The international medical business (medical tourism) has not yet returned to pre-pandemic levels but is gradually recovering, and revenue has increased significantly year on year. In anticipation of further demand growth, we are strengthening our operating structure, including by building networks with domestic medical institutions.」
Although the international medical business has not recovered to pre-pandemic levels, revenue increased significantly year on year, and the company continues to build networks with domestic medical institutions. - FY2023-Q2AdvancedAnnual report
「The international medical business (medical tourism) has not yet returned to pre-pandemic levels but is gradually recovering, and revenue has increased year on year. We are strengthening our networks with domestic medical institutions in anticipation of the easing of travel restrictions and other measures in each country.」
Although the international medical business has not returned to pre-pandemic levels, revenue has increased year on year, and the company continues to strengthen its networks with domestic medical institutions. - FY2023-Q1AdvancedAnnual report
「The international medical business (medical tourism) continues to be affected by COVID-19 and has not returned to pre-pandemic levels, but revenue has increased year on year. As entry restrictions have eased, inquiries from new customers and from people previously treated or examined in Japan have begun to increase, raising expectations for a future recovery in performance.」
The international medical business has not returned to pre-pandemic levels, while revenue has increased year on year and inquiries from new and former customers have also increased since entry restrictions were eased. - FY2022-Q3AdvancedAnnual report
「The international medical business (medical tourism) continues to be affected by COVID-19 and has not returned to pre-pandemic levels, but revenue has increased year on year. As entry restrictions have eased, inquiries from new customers and from people previously treated or examined in Japan have begun to increase, raising expectations for a future recovery in performance.」
Although the international medical business has not returned to pre-pandemic levels, revenue increased year on year, and inquiries from new and former customers increased as entry restrictions eased. - FY2022-Q2Slight revenue growth from a low levelAnnual report
「In the international medical business (medical tourism), opportunities to provide services have not returned to pre-pandemic levels because restrictions on overseas travel and other activities related to COVID-19 remain in place. Nevertheless, revenue has increased slightly year on year. We are strengthening our networks with domestic medical institutions in anticipation of the easing of travel restrictions and other measures in each country.」
Although opportunities to provide services in the international medical business have not returned to pre-pandemic levels, revenue increased slightly year on year, and the company continues to strengthen its network of domestic medical institutions. - FY2021-Q3RestatedAnnual report
「In the international medical business, opportunities to provide services have fallen sharply as restrictions on overseas travel and other activities related to the spread of COVID-19 remain in place. We are strengthening our networks with domestic medical institutions in anticipation of the easing of travel restrictions in each country.」
As opportunities to provide services in the international medical business have fallen sharply, the company continues to strengthen its network of domestic medical institutions in anticipation of reopening after travel restrictions are eased. - FY2021-Q2RestatedAnnual report
「The international medical business is among those most vulnerable to COVID-19 because all customers who come to Japan for treatment or medical examinations are foreign nationals. Revenue remains depressed because countries continued to impose travel restrictions and other measures as infections from new variants spread.」
The international medical business responsible for the international expansion of Japanese medical services continues to see depressed revenue because infections from new variants are spreading and travel restrictions remain in place. - FY2021-Q1RestatedAnnual report
「The international medical business is among those most vulnerable to COVID-19 because all customers who come to Japan for treatment or medical examinations are foreign nationals. Revenue declined significantly year on year as entry restrictions on foreign nationals arriving from overseas remained in place because of the impact of COVID-19.」
The company continues to report a situation in which revenue in the international expansion of Japanese medical services has declined significantly because entry restrictions on foreign nationals remain in place. - FY2020WorsenedAnnual report
「After the COVID-19 pandemic subsides, we expect steady revenue growth, centered on support for receiving foreign patients, in the business supporting and promoting the international expansion of Japanese medical services.」
While revenue growth is expected after the recovery, medical tourism revenue declined significantly during the fiscal year because of entry restrictions. - FY2020-Q3RestatedAnnual report
「In the international medical business, restrictions on overseas travel and lockdowns related to the spread of COVID-19 remain in place, and opportunities to provide services have almost come to a halt. We are working to strengthen our networks with domestic medical institutions in preparation for restarting the business.」
Opportunities to provide services in the international medical business have almost ceased, while the company continues to strengthen its network of domestic medical institutions in preparation for reopening. - FY2020-Q2WorsenedAnnual report
「In the international medical business, opportunities to provide services have almost come to a halt because countries around the world have restricted overseas travel or imposed lockdowns as COVID-19 spread. We are working to strengthen our networks with domestic medical institutions in preparation for restarting the business.」
The business environment for the international medical business deteriorated to the point that opportunities to receive foreign patients almost ceased. Meanwhile, the company continues to strengthen its network of domestic medical institutions in preparation for reopening. - FY2020-Q1Deterioration in the business environment due to COVID-19Annual report
「The international medical business is the most vulnerable to the impact of COVID-19 because all customers who come to Japan for treatment or medical examinations are foreign nationals. However, as noted above, conditions through almost the end of January showed that the number of patients received increased, supported by stronger networking activities with domestic medical institutions and an improved patient-receiving environment.」
In the international expansion of Japanese medical services, the number of patients received increased through the end of January, while the business was classified as the most vulnerable to COVID-19 because all customers are foreign nationals. - FY2019AdvancedAnnual report
「In the international medical business (medical tourism), the number of patients received increased, supported by stronger networking activities with domestic medical institutions and an improved patient-receiving environment, and revenue reached a record high.」
The number of foreign patients received increased, supported by stronger networks with domestic medical institutions, and revenue from the international medical business reached a record high. - FY2019-Q3AdvancedAnnual report
「In the international medical business, which receives foreign patients, steady results were achieved as awareness of Japan's advanced medical care increased and the number of medical institutions receiving foreign patients grew. In September, the business recorded its highest-ever revenue.」
The company cites the international medical business's concrete results, including record-high revenue in September, as part of the international expansion of Japanese medical services. - FY2019-Q1AdvancedAnnual report
「In the international medical business, the number of patients received increased, supported by stronger networking activities with domestic medical institutions and an improved environment for receiving patients.」
The company states that, as part of the international expansion of Japanese medical services, the number of patients received increased, supported by stronger networks with domestic medical institutions. - FY2018AdvancedAnnual report
「In the international medical business, the number of patients received increased, supported by stronger networking activities with domestic medical institutions and an improved environment for receiving patients.」
As part of the international expansion of Japanese medical services, the number of foreign patients received increased, supported by stronger networks with domestic medical institutions. - FY2018-Q1AdvancedAnnual report
「In April, we were selected as the subsidized project operator for a project receiving orders from the Ministry of Economy, Trade and Industry, under the subsidy program for measures related to petroleum refining technologies in oil-producing countries. This fiscal year, we will develop closer medical cooperation initiatives, with a view to fully launching medical services and training by Japanese healthcare professionals in the United Arab Emirates.」
Having been selected as a subsidized project operator by the Ministry of Economy, Trade and Industry, the medical cooperation initiative is progressing toward the full-scale launch of medical services and training by Japanese healthcare professionals in the United Arab Emirates. - FY2017RaisedAnnual report
「・Establishing an outbound medical assistance business based on increased confidence in Japanese medical care」
The scope of the objective has expanded from introducing and supporting Japanese medical care to establishing the outbound medical assistance business itself. - FY2016AdvancedAnnual report
「In the outbound business, we operate seminars introducing Japanese medical care overseas, including seminars in the Emirate of Abu Dhabi introducing Japanese medical facilities and medical technologies.」
Regarding the international deployment of Japanese medical care, the company conducts activities introducing Japanese medical facilities and technologies in Abu Dhabi and elsewhere, in addition to providing training support in Bahrain. - FY2016-Q2First statedAnnual report
「In June, as part of an initiative to introduce Japanese medical care overseas, the National Center for Global Health and Medicine, which had been commissioned by the Ministry of Health, Labour and Welfare to carry out the “FY2016 Project to Promote the International Deployment of Medical Technologies and Services,” was selected as the project operator and began implementing a project to support the training of healthcare professionals in the Kingdom of Bahrain. We will continue to support the international deployment of Japanese medical care in Bahrain and the Middle East.」
The company implemented a healthcare-professional training support project in Bahrain as an FY2016 initiative and indicated its policy of supporting the deployment of Japanese medical care in Bahrain and the Middle East.